Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson’s Disease: A Meta-Analysis of 12 Randomized Controlled Trials

By sjmartinez • July 9, 2024

Jaiswal V, Mashkoor Y, Raj N, Rajak K, Jaiswal A, Fonarow GC. Association between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled Trials. Am J Med. 2024 Jul 6:S0002-9343(24)00420-0. doi: 10.1016/j.amjmed.2024.06.030. Epub ahead of print. PMID: 38977148.

Tags: Cardiology/Epi, Dementia, diabetes mellitus, heart failure, Parkinson’s disease, Publications, SGLT2I

An implantable wireless battery-free spatially selective vagus nerve stimulator

Rutkovskis E, Ravagli E, Lancashire HT, Shah Idil A, Thompson N, Perkins JD, Challita R, Hadaya J, Vivekananda U, Ajijola O, Shivkumar K, Miserocchi A,[...]

Long-Term Outcomes of Contemporary Balloon-Expandable TAVR in Bicuspid Aortic Valve: A Propensity-Matched Comparison to Tricuspid

Suruga K, Patel V, Shitan H, Yuchao G, Nagasaka T, Ng D, Menda J, Singh A, Goyal A, Buss E, Kremenovic A, Dermand E, Jain[...]

The latest Fontan paradox: when less is more (difficult)

Moore JP, Paul T, Etheridge SP. The latest Fontan paradox: when less is more (difficult). Europace. 2026 Sep 2;28(9):euag239. doi: 10.1093/europace/euag239. PMID: 42732894; PMCID: PMC13571844.